Candler County is in the process of repairing roads impacted by flooding. They’re still dealing with impacts from Debby, Helene, and now the sudden flooding that occurred last week. As of Thursday ...

The European Union's drugs regulator reversed its decision to block the Alzheimer's drug lecanemab, a treatment aimed at ...

Northern Light Mayo Hospital will hold a small emergency preparedness drill in the Corinth area Thursday afternoon (11/14).

A key regulatory committee sided against the drug this summer. But an appeal from Eisai appears to have worked, teeing ...

After re-examining its initial opinion, EMA’s human medicines committee, or CHMP, has recommended granting a marketing authorisation to Leqembi for treating mild cognitive impairment or mild dementia ...

The Dow Jones is still trending deep into bull country regardless of any near-term drags; the index is on pace to close in the green for all but two months of 2024. The DJIA is also trading well above ...

Van Wert County Commissioners toured a potential new home for the Van Wert County Emergency Management Agency on Thursday.

Europe's medicines watchdog on Thursday partially approved a marketing request for a long-awaited new treatment for Alzheimer ...

Biogen Inc.'s stock rose 1% Thursday, after Europe's pharmaceutical regulator issued a positive opinion on the Alzheimer's disease drug that the company developed with Japanese partner Eisai - ...

1. About lecanemab (generic name, brand name: Leqembi®) Lecanemab is the result of a strategic research alliance between Eisai and BioArctic. It is a humanized immunoglobulin gamma 1 (IgG1) monoclonal ...

The agency had previously recommended against marketing authorization for the Alzheimer's disease but reconsidered after a review.

Upon reexamination, the European Medicines Agency has made a U-turn on Eisai and Biogen’s Alzheimer’s disease drug Leqembi. | ...